Recombinant human thyrotropin stimulation prior to I therapy in toxic multinodular goitre with low radioactive iodine uptake.

M J Azorín Belda, A Martínez Caballero, G C Figueroa Ardila, M Martínez Ramírez, C A Gómez Jaramillo, J I Dolado Ardit, J Verdú Rico

Journal: Revista espanola de medicina nuclear e imagen molecular 2017;36(1):7-12

PMID: 27422154

Abstract

AIM

Stimulation with recombinant human thyrotropin (rhTSH) increases thyroid radioiodine uptake, and is an aid to I therapy in non-toxic multinodular goitre (MNG). However, there are not many studies using rhTSH prior to I in toxic multinodular goitre to improve hyperthyroidism and compressive symptoms.

MATERIAL AND METHOD

A prospective study was conducted on patients with MNG and hyperthyroidism. Patients were recruited consecutively and divided into group I, stimulated with 0.3mg of rhTSH before radioiodine therapy, and a control group or group II, without stimulation. Thyroid function, radioiodine thyroid uptake, thyroid weight, and compressive symptoms were measured, and patients were followed-up for 9 months.

RESULTS

Group I consisted of 16 patients (14 women), with a mean age 69.7 years, and group II with 16 patients (12 women), with a mean age 70.7 years. After stimulation with 0.3mg rhTSH in group I, I uptake (RAIU) at 24h increased by 78.4%, and the estimated absorbed dose by 89.3%. In group II, the estimated absorbed dose was lower than group I after stimulation with rhTSH (29.8Gy vs. 56.4Gy; P=0.001). At 9 months of follow-up, hyperthyroidism was controlled in 87.5% of patients in group I, and 56.2% in group II (P=0.049). The mean reduction in thyroid weight was higher in group I than in group II (39.3% vs. 26.9%; P=0.017), with a tendency towards subjective improvement of compressive symptoms in group I, although non-significant. Only 2 patients described tachycardias after rhTSH administration, which were resolved with beta-blockers.

CONCLUSION

Stimulation with 0.3mg of recombinant human thyrotropin prior to radioiodine therapy achieves a reduction in thyroid weight and functional improvement in patients with hyperthyroidism and multinodular goitre with low uptake, and with no need for hospital admission.

Copyright © 2016 Elsevier España, S.L.U. y SEMNIM. All rights reserved.

Address: Hospital Universitario de San Juan de Alicante, San Juan de Alicante, España. Electronic address: [email protected].; Hospital Universitario de San Juan de Alicante, San Juan de Alicante, España.

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.